NDC 69639-105

AKYNZEO

Fosnetupitant And Palonosetron

AKYNZEO is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Helsinn Therapeutics (u.s.), Inc.. The primary component is Fosnetupitant; Palonosetron Hydrochloride.

• Product ID: 69639-105_7c25ad52-d737-489f-b229-1e2a6fa0add1
• NDC: 69639-105
• Product Type: Human Prescription Drug
• Proprietary Name: AKYNZEO
• Generic Name: Fosnetupitant And Palonosetron
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2020-06-15
• Marketing Category: NDA / NDA
• Application Number: NDA210493
• Labeler Name: Helsinn Therapeutics (U.S.), Inc.
• Substance Name: FOSNETUPITANT; PALONOSETRON HYDROCHLORIDE
• Active Ingredient Strength: 260 mg/20mL; mg/20mL
• Pharm Classes: Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 69639-105-01

1 VIAL in 1 CARTON (69639-105-01) > 20 mL in 1 VIAL

• Marketing Start Date: 2020-06-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "AKYNZEO" or generic name "Fosnetupitant And Palonosetron"

NDC	Brand Name	Generic Name
69639-101	AKYNZEO	Netupitant and Palonosetron
69639-102	AKYNZEO	Fosnetupitant and Palonosetron
69639-105	AKYNZEO	Fosnetupitant and Palonosetron